Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The "Stimufit" tincture is safe and effective for treating hair loss.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Some herbs show promise as antiandrogenic agents.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

GnRH treatment can reduce breast cancer cell invasion.

Clofazimine may be effective for treating ashy dermatosis.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Compound 4 is a promising treatment for hair loss with low toxicity.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The new gel for hair loss is safe, effective, and reduces side effects.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Tofacitinib might be used to treat hair loss.